Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 : a new virus and a new case presentation
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ..
An 11-year-old boy presented with features resembling those described in health alerts on Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS), including persistent fever, haemodynamic instability and abdominal pain. Laboratory tests, including raised inflammatory markers, D-dimer, troponin and a coagulopathy, were consistent with PIMS-TS. Our patient required transfer to the paediatric intensive care unit; an echocardiography revealed left ventricular dysfunction. He was treated with intravenous immunoglobulins (Igs), corticosteroids and aspirin, with full resolution of clinical symptoms. A follow-up echocardiogram 1 month after discharge was unremarkable.Three SARS-CoV-2 PCRs on respiratory samples, taken over the initial 4-day period, were negative, as was a SARS-CoV-2 PCR on faeces 1 month after presentation; titres of IgG were clearly elevated. The negative PCRs in the presence of elevated titres of IgG suggest that the inflammatory syndrome might have developed in a late phase of COVID-19 infection when the virus was no longer detectable in the upper airway.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
BMJ case reports - 13(2020), 12 vom: 09. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Makiello, Phoebe [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 16.12.2020 Date Revised 18.10.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/bcr-2020-238531 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM318639629 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM318639629 | ||
003 | DE-627 | ||
005 | 20231225165755.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bcr-2020-238531 |2 doi | |
028 | 5 | 2 | |a pubmed24n1062.xml |
035 | |a (DE-627)NLM318639629 | ||
035 | |a (NLM)33298501 | ||
035 | |a (PII)e238531 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Makiello, Phoebe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 |b a new virus and a new case presentation |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2020 | ||
500 | |a Date Revised 18.10.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a An 11-year-old boy presented with features resembling those described in health alerts on Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS), including persistent fever, haemodynamic instability and abdominal pain. Laboratory tests, including raised inflammatory markers, D-dimer, troponin and a coagulopathy, were consistent with PIMS-TS. Our patient required transfer to the paediatric intensive care unit; an echocardiography revealed left ventricular dysfunction. He was treated with intravenous immunoglobulins (Igs), corticosteroids and aspirin, with full resolution of clinical symptoms. A follow-up echocardiogram 1 month after discharge was unremarkable.Three SARS-CoV-2 PCRs on respiratory samples, taken over the initial 4-day period, were negative, as was a SARS-CoV-2 PCR on faeces 1 month after presentation; titres of IgG were clearly elevated. The negative PCRs in the presence of elevated titres of IgG suggest that the inflammatory syndrome might have developed in a late phase of COVID-19 infection when the virus was no longer detectable in the upper airway | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a cardiovascular medicine | |
650 | 4 | |a immunological products and vaccines | |
650 | 4 | |a infectious diseases | |
650 | 4 | |a paediatric intensive care | |
650 | 4 | |a paediatrics | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Immunoglobulins, Intravenous |2 NLM | |
650 | 7 | |a Aspirin |2 NLM | |
650 | 7 | |a R16CO5Y76E |2 NLM | |
700 | 1 | |a Svirpliene, Sima |e verfasserin |4 aut | |
700 | 1 | |a Finlay, Lisa |e verfasserin |4 aut | |
700 | 1 | |a McKnight, Jean |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ case reports |d 2008 |g 13(2020), 12 vom: 09. Dez. |w (DE-627)NLM209291001 |x 1757-790X |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2020 |g number:12 |g day:09 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bcr-2020-238531 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2020 |e 12 |b 09 |c 12 |